Basic Science: The Foundation for an ALS Cure
Basic Science conducted by investigators at Northwestern’s Les Turner ALS Center is building a foundation for future ALS care.
Browsing: Disease Discoveries
Scientists Identify New Therapeutic Target in Diabetes
Northwestern Medicine scientists have shown for the first time how an RNA-binding protein in the liver plays an important role in regulating insulin sensitivity throughout the body.
Feinberg Pioneers LGBT Study Methods
Improving recruitment and data collection is a central area of focus for Northwestern’s Institute for Sexual and Gender Minority Health and Wellbeing, the largest LGBT health-focused research center in the country.
Scientists Examine Epigenetics of Breast Cancer
Northwestern Medicine scientists are using a variety of innovative techniques to uncover the epigenetics of breast cancer, as seen in three recent studies.
Cellular Mechanism Protects Organs During Iron Deficiency
A protein called tristetraprolin is activated during iron deficiency, lowering iron usage and preventing mitochondrial dysfunction, according to a recent Northwestern Medicine study.
Why Internal Scars Won’t Stop Growing
A new Northwestern Medicine study has identified a trigger of some fibrotic diseases and an experimental compound to treat it.
Leading World-Class Investigations Into Infectious Diseases
Feinberg scientists are confronting significant, global challenges — from antimicrobial resistance to HIV — through collaborative, cutting-edge basic science and clinical research within the Division of Infectious Diseases.
Drug Protects Neurons in Parkinson’s Disease
Treating mice with isradipine, a calcium channel blocker, prevented formation of toxic compounds that can cause Parkinson’s disease symptoms, according to a recent Northwestern Medicine study.
New Technique Helps Uncover Changes in ALS Neurons
Northwestern Medicine scientists used an innovative technique to measure electrical activity in ALS neurons, finding changes in excitability that indicated disease, according to a study published in Stem Cell Reports.
Common Antimicrobial May Raise Risk of Colon Disease
Triclosan, a common antimicrobial used in toothpastes and other products, may raise the risk of gut inflammation and colorectal cancer, according to a preliminary animal study.